- Disease area
- Laboratory services
BIOHIT’s diagnostic products are used around the globe in a variety of clinical and research settings. Our product range focuses on innovative assays for screening, diagnosing and monitoring digestive diseases and associated health risks. It includes a combination of patented and unique assays, as well as market-leading routine tests. These diagnostic kits are ideal for supporting this complex area of investigation.
We work in all tiers of healthcare, and our diagnostic tests are focused towards improving patient pathways and delivering better clinical outcomes. Much of our expertise is based around conducting clinical trials, where our dedicated customer base in pathology and gastroenterology aims to transfer our assays into routine clinical use.
BIOHIT’s series of unified kits feature methods that have been standardised across all analytes and optimised for automation. This assay is part of the BIOHIT GastroPanel product.
The BIOHIT H. pylori Quick Test is a rapid, one-step urease test to detect H. pylori infection from a biopsy sample during gastroscopy. It can also be used to evaluate the success of eradication therapy. This easy-to-use, gel-based test employs a simple colour indicator that allows easy visual confirmation of positive results in as little as two minutes – and negative results after 30 minutes – without specialist training.
The IDK H. pylori Stool Antigen ELISA is used for the detection of H. pylori in stool samples, for confirmation of active H. pylori infection in the absence of atrophic gastritis, bleeding ulcer and use of proton pump inhibitors.
The BIOHIT UFT300 Helicobacter pylori Quick Test is an ultra-fast urease test that has revolutionised the way H. pylori infection is diagnosed and reported in gastroscopy. With extremely high accuracy and every result available within five minutes, this ready-to-use test is the choice for endoscopists.
The BIOHIT Active B12 (holotranscobalamin) ELISA directly measures holotranscobalamin (holoTC) – the biochemically active form of vitamin B12 – from human serum. This test is well-suited for the screening of patients with a suspected vitamin B12 deficiency, and overcomes the problems associated with traditional testing methods that measure total, rather than just active, vitamin B12 concentration.
The IDK anti-SARS-CoV-2 quantitative IgG ELISA is for the specific detection and quantification of human IgG antibodies against the SARS-CoV-2 spike protein.
The IDK anti-SARS-CoV-2 IgG ELISA Kit is for the qualitative determination of COVID-19 IgG antibodies in serum.
The IDK anti-SARS-CoV-2 IgM ELISA is for the qualitative determination of human IgM antibodies against the SARS-CoV-2 virus in suspected COVID-19 cases.
PreventID CalDetect 50/200 is a rapid immunochemical test that semi-quantitatively screens and measures calprotectin in stool samples in just 10 minutes. Faecal calprotectin is an exceptionally accurate and convenient marker for investigating bowel inflammation in patients presenting with abdominal symptoms, or monitoring those with inflammatory bowel disease (IBD).
The BIOHIT Calprotectin ELISA is a quantitative sandwich ELISA method for the detection of calprotectin in stool samples. It can be used to help identify organic diseases of the small or large intestine, and to monitor disease activity and response to treatment in patients with ulcerative colitis or Crohn’s disease.
PreventID CalScreen is a rapid immunochemical test that screens stool samples for calprotectin in just 10 minutes. With a predefined cut-off at 50 μg/g, CalScreen enables the rapid screening of patients with chronic abdominal symptoms, and the differentiation between inflammatory and non-inflammatory bowel conditions.
The BIOHIT Celiac Quick Test is a rapid immunochromatographic test for the qualitative detection of IgA, IgG, and IgM autoantibodies against human tissue transglutaminase (tTG2A) in capillary whole blood samples.
BIOHIT ColonView Hb and Hb/Hp test can be used to screen for lower gastrointestinal (GI) organic pathologies, such as colorectal cancers and large adenomas that bleed. ColonView is a new generation lateral flow faecal immunochemical test (FIT), intended for the rapid detection of faecal occult blood (FOB) in stool samples.
The CE-marked GA-map COVID-19 Fecal Test is designed to qualitatively detect SARS-CoV-2 RNA in faecal samples. This kit is suitable for patients exhibiting symptoms of COVID-19 (confirmation and management), as well as those in the recovery phase (surveillance and clearance), asymptomatic individuals concerned about possessing and transmitting the virus (prevention), and for screening faecal microbiota transplant (FMT) donors.
The innovative IDK Faecal Bile Acids assay allows quantitative determination of bile acids in stool samples. This rapid photometric assay can aid the diagnosis of bile acid diarrhoea in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS) or can be used to support differential diagnosis of bile acid malabsorption.
The IDK Faecal Calprotectin ELISA is an enzyme immunoassay for the quantitative determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples, to rule out and monitor inflammatory bowel diseases (IBDs) non-invasively.
The IDK Faecal Haemoglobin ELISA is an enzyme immunoassay for the reliable quantitative determination of human haemoglobin in stool samples, which can be used as marker for gastrointestinal bleeding, colorectal cancer and adenomatous polyps.
The IDK Lactoferrin ELISA is an enzyme immunoassay for the quantitative determination of lactoferrin – a well-established biomarker for neutrophilic intestinal inflammation – in stool samples. Faecal lactoferrin measurement supports monitoring of disease activity in inflammatory bowel disease (IBD), prediction of relapse of IBD and assessment of treatment response in IBD.
The GA-Map Dysbiosis test is the first clinical test that identifies and characterises dysbiosis based on faecal specimens. It does this by exploiting single nucleotide differences in the 16S rRNA gene – a gene that is common to all bacteria. With 48 highly specific probes, the GA-map Dysbiosis Test identifies over 300 species of bacteria using cutting edge high throughput technology.
The BIOHIT Gastrin-17 kit is a microplate-based quantitative ELISA for the determination of human amidated gastrin-17 from plasma or serum samples. This test identifies Helicobacter pylori (H. pylori)-infected patients who have advanced atrophic gastritis in the gastric antrum.
GastroPanel is a simple blood test that aids the diagnosis of dyspepsia and is ideal for primary care settings. It is used to effectively identify atrophic gastritis and gastric cancer risk in order to select patients for referral to gastroscopy.
The BIOHIT GastroPanel Quick Test is a rapid and quantitative immunochromatographic test for the detection of Helicobacter pylori (H. pylori) and atrophic gastritis in a clinic or point-of-care setting.
The IDK TurbiCAL is a particle enhanced turbidimetric immunoassay (PETIA) that uses monoclonal antibodies for the determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples.
The IDK TurbiFIT is a particle enhanced turbidimetric immunoassay (PETIA) that uses polyclonal antibodies for the determination of human haemoglobin in stool samples.
The IDK TurbiPEL is a particle enhanced turbidimetric immunoassay (PETIA) that uses monoclonal antibodies for the determination of human pancreatic elastase in stool samples.
The BIOHIT Lactose Intolerance Quick Test supports the diagnosis of lactose intolerance (hypolactasia of the small intestine) by detecting lactase enzyme activity in a duodenal biopsy specimen.
The MutaPLEX® Coronavirus real time RT-PCR Kit is a screening assay for the simultaneous detection of RNA of the novel coronavirus (SARS-CoV-2) and other betacoronaviruses (e.g. MERS-CoV and SARS-CoV) extracted from biological specimens.
The MutaPLEX® RespiraScreen 1 real time RT-PCR Kit is a screening assay for the simultaneous detection and differentiation of the following respiratory viruses: novel coronavirus (SARS-CoV-2), influenza (A and B) and respiratory syncytial virus (RSV A and RSV B) from a single nasopharyngeal/throat sample.
The IDK Pancreatic Amylase ELISA is an enzyme immunoassay for the quantitative determination of pancreatic amylase in stool samples. This supports the diagnosis of exocrine pancreatic insufficiency in a range of cases including unexplained diarrhoea, gut microbiota, dysbiosis, IBS/IBD, steatorrhoea, flatulence, weight loss, upper abdominal pain and dietary intolerances.
The IDK Pancreatic Elastase ELISA is a quantitative enzyme immunoassay for the determination of pancreatic elastase in stool samples. This supports the diagnosis of exocrine pancreatic insufficiency in a range of cases including unexplained diarrhoea, gut microbiota, dysbiosis, IBS/IBD, steatorrhoea, flatulence, weight loss, upper abdominal pain and dietary intolerances.
The BIOHIT Pepsinogen I kit is a microplate-based quantitative ELISA for the determination of human pepsinogen I from plasma or serum samples. This test is intended to identify patients who have advanced atrophic gastritis in the gastric corpus, and are therefore at increased risk of developing gastric cancer.
The BIOHIT Pepsinogen II kit is a microplate-based quantitative ELISA for the determination of human pepsinogen II from plasma or serum samples. This test is intended as an additional tool in the diagnosis of atrophic corpus gastritis, which is also a risk state for gastric cancer.
Peptest is an innovative, non-invasive diagnostic test to help identify reflux, and is especially critical in detecting silent reflux. Based on quantitative lateral flow technology, Peptest detects the presence of pepsin in clinical samples from the upper digestive and respiratory tracts.
Preventis QuantOn Cal is a test system for the quantitative determination of calprotectin in stool samples. This in vitro diagnostic device (IVD) is intended for self-testing and individual monitoring of treatment efficacy for patients with chronic inflammatory bowel disease (IBD).
Preventis SmarTest Pro Vitamin D is a rapid test system for the quantitative determination of 25(OH) vitamin D in finger-prick blood samples, ideal for GPs, pharmacies and outpatient clinics. This quantitative test supports fast and effective vitamin D supplement optimisation, and enables close monitoring of 25(OH) vitamin D levels in a point of care setting. The kit contains everything needed to prepare, collect and test a finger-prick blood sample in combination with the SmarTest Vitamin D app.
Preventis SmarTest Calprotectin is a quantitative home test system for the determination of calprotectin in stool samples. This in vitro diagnostic device (IVD) is intended for self-testing and individual monitoring of disease activity and treatment efficacy for patients with chronic inflammatory bowel disease (IBD).
The BIOHIT Total 25OH Vitamin D ELISA is a quantitative immunoenzymatic assay for the determination of 25-hydroxyvitamins D2 and D3 (25OHD2 and 25OHD3) in serum and plasma, to aid in the diagnosis of vitamin D deficiency, insufficiency or intoxication.
The IDK Zonulin (Serum) ELISA is a quantitative assay for the determination of zonulin in serum. Zonulin is a protein that is involved in intestinal barrier function, and has been highlighted as a potential marker of so called “leaky gut” syndrome.
The IDK Zonulin (Stool) ELISA is a quantitative assay for the determination of zonulin in stool samples. Zonulin is a protein that is involved in intestinal barrier function, and has been highlighted as a potential marker of so called “leaky gut” syndrome.